Superdisintegrants Market worth $536.5 million by 2023

1. MarketsandMarkets Presents Superdisintegrants Market  www.marketsandmarkets.com

2. Factors contributing to the growth of this market include the increasing adoption of orally disintegrating tablets, growing generics market, and the emergence of new superdisintegrants for the pharmaceutical industry. The shifting focus of pharmaceutical manufacturing to emerging markets and the growth of the overall pharmaceutical sector in these markets present significant opportunities for the superdisintegrants market growth. Browse 124 market data Tables and 37 Figures spread through 182 Pages and in-depth TOC on "Superdisintegrants Market” https://www.marketsandmarkets.com/Market-Reports/superdisintegrants-market-198068672.htmlEarly buyers will receive 10% customization on reports. The superdisintegrants market is expected to reach USD 536.5 million by 2023 from an estimated USD 366.4 million in 2018, at a CAGR of 7.9%.  Superdisintegrants Market

3. The report analyzes the global superdisintegrants market by type, formulation, therapeutic area, and region. By type, the synthetic superdisintegrants segment accounted for the largest share of the market in 2017. The large share of this segment can be attributed to the extensive consumption of these superdisintegrants in various pharmaceutical drug formulations due to the advantages offered such as effectiveness at lower concentrations as compared to starch and a lesser effect on the compressibility and flowability of the dosage form. Download FREE Brochure @. https://www.marketsandmarkets.com/pdfdownload.asp?id=198068672 Based on formulation, the tablets segment accounted for the larger share of the global superdisintegrants market in 2017. The large share of this segment can be attributed to tablets being the most widely used dosage forms due to the benefits offered such as stability, low manufacturing cost (as compared to other dosage forms), easy product identification, and compactness, along with the increasing focus on orally disintegrating tablets and fast-dissolving tablets. http://www.marketsandmarkets.com/Market-Reports/asian-home-health-care-market-227642968.html Superdisintegrants Market

4. Geographically, the global superdisintegrants market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2017, Europe accounted for the largest share of the superdisintegrants market, followed by North America and Asia Pacific. The dominance of the European region can be attributed to the presence of a number of pharmaceutical giants with large production capacities leading to extensive consumption of excipients. The growing emphasis on superior pharmaceutical products and generics is also expected to aid the market growth in the region. Superdisintegrants Market

5. Based on therapeutic area, the neurological diseases segment is expected to register the highest CAGR during the forecast period. This can be attributed to the increasing incidences of neurological disorders at the global level along with the growing demand for effective therapies. Speak To Analyst @ https://www.marketsandmarkets.com/speaktoanalyst.asp?id=198068672 Safety and quality concerns are expected to challenge the growth of the superdisintegrants market to a certain extent during the forecast period. The prominent players in the global superdisintegrants market are Ashland Inc. (US), BASF SE (Germany), DowDuPont (US), JRS Pharma (Germany), DFE Pharma (Germany), Roquette (France), Asahi Kasei Corporation (Japan), Merck KGaA (Germany), Corel Pharma Chem (India), and Avantor Performance Materials, LLC (US). Superdisintegrants Market

6. About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Superdisintegrants Market

7. Contact Us Contact:Mr. Shelly SinghMarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA : 1-888-600-6441 sales@marketsandmarkets.com https://www.marketsandmarkets.com/ResearchInsight/healthcare-chatbots-market.asp